Treatment Patterns of Patients With Multiple Myeloma in a Real-World Setting in Spain. How are Triple-Class Exposed Patients Being Managed?
This study shows the increasingly incidence of TCE-MM patients, appearing from the first LOT. TCE treatment is challenging and identifying treatments with new mechanism of actions regardless of LOTs, will be key to optimize the management of this population.
Authors
- Tamara Iglesias (ORCID: https://orcid.org/0000-0002-1623-1677)
- Julia Llinares
- María‐Victoria Mateos (ORCID: https://orcid.org/0000-0003-2390-1218)
- Pablo Rebollo (ORCID: https://orcid.org/0000-0002-7517-6540)
- Sofía Toribio-Castelló (ORCID: https://orcid.org/0000-0001-8879-3057)
- Ana Heredero
- I. Ricote
- Luis Fernando García (ORCID: https://orcid.org/0000-0003-0157-9811)
Institutions
- Saint Louis University (ES)
- Instituto Químico Biológico (ES)
- Instituto de Investigación Biomédica de Salamanca (ES)
- Centro de Investigación del Cáncer (ES)
- Pfizer (Spain) (ES)
Publication Details
- Journal
- Clinical Lymphoma Myeloma & Leukemia
- Published
- 2025-07-19
- DOI
- https://doi.org/10.1016/j.clml.2025.07.008
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer